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ABSTRACT 
In the present study, we describe the development of a DNA vaccine against chicken anemia 
virus. The VP1 and VP2 genes of CAV were amplified and cloned into pBudCE4.1 to 
construct two DNA vaccines, namely, pBudVP1 and pBudVP2-VP1. In vitro and in vivo 
studies showed that co-expression of VP1 with VP2 are required to induce significant levels 
of antibody against CAV. Subsequently, the vaccines were tested in 2-week-old SPF chickens. 
Chickens immunized with the DNA-plasmid pBudVP2-VP1 showed positive neutralizing 
antibody titer against CAV. Furthermore, VP1-specific proliferation induction of splenocytes 
and also high serum levels of Th1 cytokines, IL-2 and IFN-γ were detected in the pBudVP2-
VP1-vaccinated chickens. These results suggest that the recombinant DNA plasmid co-
expressing VP1 and VP2 can be used as a potential DNA vaccine against CAV. 
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